Forskningsoutput per år
Forskningsoutput per år
Forskningsoutput
- 4 resultat
Sökresultat
-
2014
Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival
Flouri, I., Markatseli, T. E., Voulgari, P. V., Boki, K. A., Papadopoulos, I., Settas, L., Zisopoulos, D., Skopouli, F. N., Iliopoulos, A., Bertsias, G. K., Geborek, P., Drosos, A. A., Boumpas, D. T. & Sidiropoulos, P., 2014, I: Seminars in Arthritis and Rheumatism. 43, 4, s. 447-457Forskningsoutput: Tidskriftsbidrag › Översiktsartikel › Peer review
-
2011
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases
van Assen, S., Elkayam, O., Agmon-Levin, N., Cervera, R., Doran, M. F., Dougados, M., Emery, P., Geborek, P., Ioannidis, J. P. A., Jayne, D. R. W., Kallenberg, C. G. M., Mueller-Ladner, U., Shoenfeld, Y., Stojanovich, L., Valesini, G., Wulffraat, N. M. & Bijl, M., 2011, I: Autoimmunity Reviews. 10, 6, s. 341-352Forskningsoutput: Tidskriftsbidrag › Översiktsartikel › Peer review
-
2006
Swedish registers to examine drug safety and clinical issues in RA
Askling, J., Fored, C., Geborek, P., Jacobsson, L., van Vollenhoven, R., Feltelius, N., Lindblad, S. & Klareskog, L., 2006, I: Annals of the Rheumatic Diseases. 65, 6, s. 707-712Forskningsoutput: Tidskriftsbidrag › Översiktsartikel › Peer review
-
2004
TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden.
Kobelt, G., Eberhardt, K. & Geborek, P., 2004, I: Annals of the Rheumatic Diseases. 63, 1, s. 4-10Forskningsoutput: Tidskriftsbidrag › Översiktsartikel › Peer review
Öppen tillgångFil284 Nedladdningar (Pure)